News
AIMDW
0.1160
0.00%
0.0000
Weekly Report: what happened at AIMDW last week (0316-0320)?
Weekly Report · 6d ago
Ainos signs deployment of 1,400 AI Nose systems in backend semiconductor environments
Reuters · 03/19 12:04
Weekly Report: what happened at AIMDW last week (0309-0313)?
Weekly Report · 03/16 09:48
Ainos plans 200 AI Nose deployments in front-end wafer fabs in 1Q26
Reuters · 03/12 12:31
Ainos to deploy about 200 AI Nose systems in front-end wafer fabs in Q1 2026
Reuters · 03/09 12:30
Weekly Report: what happened at AIMDW last week (0302-0306)?
Weekly Report · 03/09 09:49
Ainos Confirms Initial Order for 1,400 AI Nose Systems Under Three-Year Subscription Deal
Reuters · 03/02 13:30
Weekly Report: what happened at AIMDW last week (0223-0227)?
Weekly Report · 03/02 09:49
Ainos Activates Phased Industrial Deployment Roadmap To Install Up To 20K AI Nose Units
Benzinga · 02/23 13:42
Ainos confirms order for 1,400 AI Nose units under three-year subscription deal
Reuters · 02/23 13:31
Weekly Report: what happened at AIMDW last week (0216-0220)?
Weekly Report · 02/23 09:49
Ainos Reports Promising Interim Results for VELDONA in Feline Gingivostomatitis Trial
Reuters · 02/17 13:01
Weekly Report: what happened at AIMDW last week (0209-0213)?
Weekly Report · 02/16 09:48
Ainos Launches Live AI Nose Deployments Under $2.1 Million Semiconductor Order
Reuters · 02/09 13:01
Ainos Inc. startet AI Nose Deployments im Rahmen eines 2,1-Millionen-Dollar-Auftrags im Halbleiterbereich
Reuters · 02/09 13:01
Weekly Report: what happened at AIMDW last week (0202-0206)?
Weekly Report · 02/09 09:49
Ainos Partners with Mirle to Expand AI Nose Robotics in Industrial Markets
Reuters · 02/05 13:02
Ainos Inc. kooperiert mit Mirle zur Integration von SmellTech in Industrieroboter
Reuters · 02/05 13:02
Water Tower Research Highlights Ainos Inc. SmellTech Expansion and AI Nose Deployments
Reuters · 02/04 13:02
Ainos erweitert SmellTech-Plattform mit KI-Nase und neuen Industrieaufträgen
Reuters · 02/04 13:02
More
Webull provides a variety of real-time AIMDW stock news. You can receive the latest news about AINOS INC through multiple platforms. This information may help you make smarter investment decisions.
About AIMDW
Ainos, Inc. is a diversified healthcare company, which is focused on the development of point-of-care testing (POCT), low-dose VELDONA interferon therapeutics and synthetic Ribonucleic Acid (RNA)-driven preventative medicine. The Company's products include VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. VELDONA Pet is formulated to address a variety of health issues in dogs and cats, including skin, gum, emotion, discomfort caused by allergies, eye, and weight-related issues. Its pipeline of products, which are under development, includes VELDONA human drugs, VOC POCT-Ainos Flora, VOC platform-NISD co-development, VOC POCT-Ainos Pen, VOC POCT-CHS430 and Synthetic RNA. VELDONA human drugs are the high-priority programs include oral warts for human immunodeficiency virus seropositive patients, common cold, influenza, Sjogrens syndrome and treatment for mild COVID-19 symptoms.